A new analysis reveals that acute MI and ischemic stroke are a part of the clinical landscape of COVID-19 and highlights the need for vaccination against the virus.
Needless platelet activity in the lungs may be one of the primary reasons clinicians are seeing inflammation and blood clotting in critically ill COVID-19 patients.
Unhealthy lifestyle decisions and a fear of catching COVID-19 are putting people at an increased risk of heart disease, according to the American Heart Association.
Wall Street stumbled Monday, July 19, and experts are blaming the COVID-19 Delta variant.
In fact, researchers found, most children were discharged from the hospital within a few days.
"This is a safe and affordable new data point that can clue us in about who might develop atrial fibrillation," one researcher said.
Researchers explored the "prolonged physiological impact of COVID-19" in a research letter published in JAMA Network Open.
Patients presenting with an acute myocardial infarction during the start of the COVID-19 pandemic faced delays in care and a higher risk of developing heart failure.
The patient, a 78-year-old female, began showing signs of a negative reaction within 20 hours.
In a new statement, the CDC, American Heart Association and several other healthcare organizations highlighted the continued importance of vaccination.
“Given the potential morbidity of COVID-19 infection even in younger adults, the risk-benefit decision for vaccination remains highly favorable," researchers wrote.
The study's authors used more than 34,000 ECGs to train and test their model, publishing their findings in Mayo Clinic Proceedings.